PNR approved for the MIA (IMP) QP oversight license

PNR Pharma currently has IMP, MIA and WDA licences authorised by the HPRA. Allowing the QP certification of both clinical and commercial supplies within the EU. As part of the expansion plans, PNR has been recently audited by the MHRA and has been approved for the MIA (IMP) QP oversight license thus allowing the import of clinical supplies from listed countries into the UK.